Updated efficacy and safety of KEYNOTE-052: A single-arm phase 2 study investigating first-line pembrolizumab (pembro) in cisplatin-ineligible advanced urothelial cancer (UC) Meeting Abstract
| Authors: | Vuky, J.; Balar, A. V.; Castellano, D. E.; O'Donnell, P. H.; Grivas, P.; Bellmunt, J.; Powles, T.; Bajorin, D. F.; Hahn, N. M.; De Wit, R.; Savage, M.; Pang, L.; Frenkl, T. L.; Keefe, S. M.; Plimack, E. R. |
| Abstract Title: | Updated efficacy and safety of KEYNOTE-052: A single-arm phase 2 study investigating first-line pembrolizumab (pembro) in cisplatin-ineligible advanced urothelial cancer (UC) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 247s |
| Language: | English |
| ACCESSION: | WOS:000442916002051 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.4524 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4524 -- Source: Wos |
